The Latest Analyst Ratings For Johnson & Johnson
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Johnson & Johnson (NYSE:JNJ) over the past three months, with a majority being somewhat bullish. The average 12-month price target has slightly decreased to $194.93. The company's financials show strong net margins and asset utilization, but challenges in ROE and revenue growth compared to peers.
September 19, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Johnson & Johnson has received mixed analyst ratings, with a majority being somewhat bullish. The average price target has decreased slightly, indicating cautious optimism. Financial metrics show strong net margins but challenges in ROE and revenue growth compared to peers.
The mixed analyst ratings suggest a cautious market sentiment towards JNJ. The slight decrease in average price target reflects tempered expectations. Financial metrics indicate strong profitability but highlight areas for improvement in ROE and revenue growth, which could impact investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100